share_log
Breakings ·  Dec 10, 2024 22:00
Geron Announces New Imerge Analyses Presented at Ash Suggesting Clinical Activity of Rytelo™ (Imetelstat) in Patients With Lower-Risk Mds Regardless of Type or Number of Prior Therapies
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment